Limited coverage criteria – ropinirole

Last updated on March 21, 2025

Special Authority requests can now be submitted online. It's simple and quick!

Return to Special Authority drug list
Generic name		ropinirole
Strength & form		0.25 mg/1 mg/2 mg/5 mg tablet

Special Authority criteria	Approval period
For the treatment of idiopathic Parkinson's disease, when: Patient is receiving treatment with levodopa and requires additional adjunctive therapy OR Patient cannot tolerate or has contraindications to levodopa	Indefinite

Special Authority criteria

Approval period

For the treatment of idiopathic Parkinson's disease, when:

Patient is receiving treatment with levodopa and requires additional adjunctive therapy

Patient cannot tolerate or has contraindications to levodopa

Indefinite

Practitioner exemptions

None

Special notes

None

Special Authority request form(s)

Log in to eForms
HLTH 5328 – General Special Authority request (PDF, 656KB)

Did you find what you were looking for?

The B.C. Public Service acknowledges the territories of First Nations around B.C. and is grateful to carry out our work on these lands. We acknowledge the rights, interests, priorities, and concerns of all Indigenous Peoples - First Nations, Métis, and Inuit - respecting and acknowledging their distinct cultures, histories, rights, laws, and governments.

More topics